Comment
doi: 10.1016/j.socscimed.2009.09.059.
Epub 2009 Dec 26.
On the prohibition of conflicts of interest in pharmaceutical regulation: precautionary limits and permissive challenges. A commentary on Sismondo (66:9, 2008, 1909-14) and O'Donovan and Lexchin
Affiliations
- PMID: 20056525
- DOI: 10.1016/j.socscimed.2009.09.059
Item in Clipboard
Comment
On the prohibition of conflicts of interest in pharmaceutical regulation: precautionary limits and permissive challenges. A commentary on Sismondo (66:9, 2008, 1909-14) and O'Donovan and Lexchin
Soc Sci Med.
2010 Mar.
No abstract available
Comment on
-
How pharmaceutical industry funding affects trial outcomes: causal structures and responses.Soc Sci Med. 2008 May;66(9):1909-14. doi: 10.1016/j.socscimed.2008.01.010. Epub 2008 Mar 4. Soc Sci Med. 2008. PMID: 18299169
-
Prohibiting or 'managing' conflict of interest? A review of policies and procedures in three European drug regulation agencies.Soc Sci Med. 2010 Mar;70(5):643-7. doi: 10.1016/j.socscimed.2009.09.002. Epub 2009 Sep 24. Soc Sci Med. 2010. PMID: 19782458 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
